UNSPSC 51171523: Carbaldrate

This classification denotes an anti-ulcer agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 6931E8LH07. European Medicines Agency schedules Carbaldrate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06112MIG. Carbaldrate generally arises in the molecular formula CO3.AL.NA.2HO.H2O.

UNSPSC 51171523 Carbohydrate is a Commodity code that encompasses pharmaceutical and medical testing products including generic pharmaceuticals, over-the-counter medications, and drug testing supplies used in correctional and healthcare settings. State and local governments procure under this code through a mix of issuing bodies including state health and human services agencies, county community supervision departments, and multistate cooperative purchasing alliances. The scope of work includes direct pharmaceutical supply agreements, drug testing services with laboratory confirmation methodologies, and bulk pharmaceutical distribution through authorized wholesalers serving multiple government jurisdictions and facilities. Procurement structures range from formal competitive RFPs establishing multi-vendor contracts to exploratory RFIs gathering market intelligence on direct-to-manufacturer models outside traditional pharmacy benefit manager arrangements.

Recent activity spans Texas and Minnesota with participation from multistate cooperative purchasing networks. Collin County Community Supervision and Corrections Department issued RFP 2026-327 (due July 23, 2026) for offender specimen collection and drug testing services, an estimated $600,000 contract with a two-year base term and three optional one-year renewals, requiring SAMHSA- or CAP-certified lab capacity and staffing at two collection sites with approximately 25,031 annual tests comprising five-panel and six-panel immunoassay screening with LC/MS/MS or GC/MS confirmation. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) administered by the Minnesota Department of Administration issued an RFP (due March 26, 2026) for generic multi-source pharmaceuticals and OTC products distributed across participating state and local government facilities in Minnesota and Oregon, requiring vendor pricing for identified NDCs through three authorized wholesalers with two-year contract terms and 3 percent administrative fees. The Texas Health and Human Services Commission issued RFI No. HHS0017013 (posted March 27, 2026) to gather vendor capabilities for a Therapeutic Pharmacy Initiative Direct-to-Manufacturer Prescriptions program seeking direct contracting capacity outside traditional PBM and wholesaler channels, positioning the state for subsequent formal RFP issuance after information-gathering concludes.